CDK4 and Decreased total neutrophil count: Thus, the neutropenia observed in the clinic with CDK4/6 inhibitors is a consequence of the on-target effect of prolonged drug exposure, which has resulted in dosing regimens that require at least a 7-day treatment holiday to allow recovery of neutrophils.